Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON.
Curr Oncol. 2012 Aug;19(4):e232-8. doi: 10.3747/co.19.944.
Multidisciplinary cancer conferences (mccs) are designed to optimize patient outcomes. It appears intuitive that mccs are essential to clinical decision-making and patient management; however, it is unclear whether that belief is supported by evidence. Our objectives were to assess the currently published literature addressing the impact of mccs on clinical decision-making and patient outcomes.
Ovid medline was searched from 1950 to June 2010 using these keywords: "multidisciplinary/interdisciplinary/clinical meeting$/conference$/round$/team$," "decision making," "neoplasms$/cancer$/oncology/tumo(u)r conference$/board$/meeting$," "multidisciplinary/interdisciplinary cancer conference$/meeting$." All trials, guidelines, metaanalyses, reviews, and prospective and retrospective studies were included.
The keywords retrieved 595 abstracts, and 30 manuscripts were obtained. Most of the studies assessed the impact of mccs on clinical decision-making rather than on patient outcomes.
Available evidence supports the belief that mccs significantly influence clinical decision-making and treatment recommendations. In contrast, scant evidence suggests that mccs improve patient outcomes. Unfortunately, the current literature is substantially heterogeneous and therefore does not allow for firm conclusions.
多学科癌症会议（mccs）旨在优化患者的治疗效果。mccs 对于临床决策和患者管理至关重要，这似乎是显而易见的，但这种观点是否有证据支持还不清楚。我们的目的是评估目前已发表的关于 mccs 对临床决策和患者预后影响的文献。
通过使用这些关键词在 Ovid medline 上进行检索：“多学科/跨学科/临床会议/会议/小组”、“决策”、“肿瘤/癌症/肿瘤学/肿瘤会议/委员会/会议”。纳入所有的试验、指南、荟萃分析、综述以及前瞻性和回顾性研究。
关键词检索出 595 个摘要，获得了 30 篇文章。大多数研究评估了 mccs 对临床决策的影响，而不是对患者预后的影响。
现有证据支持这样一种观点，即 mccs 显著影响临床决策和治疗建议。相比之下，很少有证据表明 mccs 能改善患者的预后。不幸的是，目前的文献存在很大的异质性，因此无法得出明确的结论。
